Skip to main content

5 Best Stories on Real Money: Cramer's Electric Gold, Bonds and Biotech

Here are five must reads from Jim Cramer, Jim "Rev Shark" DePorre, and the team at Real Money/Real Money Pro!
  • Author:
  • Publish date:

You can't lip service electric vehicles anymore, as Exxon's board moves indicate.

Will the bond market hold here or has the Fed already started working behind the scenes supporting it?

The most critical factor in long-term trading market success is the ability to effectively navigate market corrections.

There's potential to turn Verizon from a stable telecom into a "growthy" type name.

One biotech has inked a supply deal related to a COVID-19 vaccine that could greatly increase its revenue stream.

It's all on Real Money right now.

Here are five must reads from the columnists of Real Money and Real Money Pro, our premium sites for Wall Street professionals and active investors:

Jim Cramer: There's No Stopping the Electric Gold Rush

The premier oil company ever since John D. Rockefeller created it, Exxon Mobil  (XOM)  , announced that it is adding Jeffrey Ubben, a brilliant investor, to its board, in order to put a powerful voice in the room to make Exxon more carbon free, writes Jim Cramer.

This is monumental and, more important, it says that Exxon knows that its gasoline days are numbered.

Maleeha Bengali: Are Bonds Truly a Hedge for an Equity Portfolio?

As March starts in earnest, people are sitting down trying to decide how to allocate their assets going forward. Seeing their 60/40 (stocks/bonds) crater over the last few weeks, perhaps there is a rude awakening. 

It seems soon the Fed will need to be the buyer of last resort. They cannot afford a loss of control in the U.S. bond market, explains Maleeha Bengali.

Rev Shark: Navigating a Market Correction

Market corrections are inevitable and present the most significant challenge that traders and investors will face. 

Many will hold onto positions and even add to them with the belief that the market will recover and bail them out once again. But eventually comes a day when the market doesn't cooperate and they will sell in dismay as they can no longer stand the pain, says James "Rev Shark" DePorre.

Stephen Guilfoyle: Verizon - The Risk Is to the Upside

With the enormous popularity of gaming names, there is potential to turn Verizon  (VZ)  from a stable telecom into a "growthy" type name. The potential is the "Verizon Media Group", notes Stephen Guilfoyle.

Bret Jensen: Biotech Isn't Seeing Much Merger Activity, but Here's a Stock to Like

Biotech was one of the biggest losers in the market last week. Even with the pullback, however, the SPDR S&P Biotech ETF  (XBI)  is up over 60% in the past year, observes Bret Jensen.

Jensen used last week's market selloff to add to some core biotech holdings in his portfolio via covered call orders, including this significant play in the COVID-19 space. 


Real Money and Real Money Pro are TheStreet's premium sites for active traders. Click here to get great columns like these from Jim Cramer, Stephen "Sarge" Guilfoyle, Doug Kass and other writers each trading day.